publication date: Sep. 20, 2013

Vol. 39, No. 35 – 

Patient Harm—Including One Death—Cited As Faculty Challenges MD Anderson Leadership ODAC Recommendation for Pertuzumab Signals FDA’s Resolve In Granting Accelerated Approvals HHS, NIH Prepare for Government Shutdown FDA Approves Generic Capecitabine

Download the PDF

Documents referenced in this issue of The Cancer Letter can be found here

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.